ISRG posts 20% Q3 procedure growth as da Vinci and Ion volumes accelerate, but investors question if product cycles and timing effects can sustain it.
Brookstone Capital Management increased its stake in Intuitive Surgical, Inc. (NASDAQ: ISRG) by 48.7% during the third quarter, according to the company in its most recent 13F filing with the SEC. The
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
Intuitive Surgical's robotics-first model, recurring revenue base, and margin leverage differentiate it from Stryker in terms of upside potential today.
Global X Japan Co. Ltd. reduced its stake in shares of Intuitive Surgical, Inc. (NASDAQ: ISRG) by 6.8% in the undefined quarter, according to the company in its most recent 13F filing with the Securit
Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.
Four large-cap MedTech leaders, MDT, ISRG, CAH, EW, appear well-positioned to extend their winning streaks in 2026 on resilient procedure demand and innovation.
Perpetual Ltd reduced its stake in Intuitive Surgical, Inc. (NASDAQ: ISRG) by 99.2% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Co
Congress Asset Management Co. boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ: ISRG) by 1.2% in the third quarter, according to the company in its most recent 13F filing with the Se
Cyndeo Wealth Partners LLC trimmed its position in Intuitive Surgical, Inc. (NASDAQ: ISRG) by 31.6% during the third quarter, according to its most recent filing with the Securities and Exchange Commi
Central Bank and Trust Co. reduced its holdings in Intuitive Surgical, Inc. (NASDAQ: ISRG) by 8.6% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Co
In the most recent trading session, Intuitive Surgical, Inc. (ISRG) closed at $572.47, indicating a +1.88% shift from the previous trading day.
The Investment Committee's latest market picks.
ISRG plans a 2026 shift to direct distribution in Italy, Spain, and Portugal, aiming to lift margins by capturing distributor economics with execution risk.
Novo Nordisk's new indications for semaglutide and its attractive pipeline could allow it to bounce back. Intuitive Surgical should remain the leader in its niche despite increased competition.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE